


Searching News Database: Prime Therapeutics
HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
HSMN NewsFeed - 17 Jul 2017
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
Phoenix Molecular Designs Appoints Leading Oncology Expert Dr. Gerrit Los as Chief Scientific Officer
HSMN NewsFeed - 9 Feb 2015
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
InVivo Therapeutics Appoints Lorianne Masuoka, MD as Chief Medical Officer
HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
HSMN NewsFeed - 17 Sep 2009
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
Juvaris BioTherapeutics Announces First Close on $25 million Series B Financing
HSMN NewsFeed - 9 Jun 2009
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Chief Medical Officer
Additional items found! 3
Members Archive contains
3 additional stories matching:
Prime Therapeutics
(Password required)
Prime Therapeutics
(Password required)
